Medication info
Tenelrod M Extended-release Tablet 10/500 mg

Tenelrod M Extended-release Tablet 10/500 mg

Prescription medicationTablet경구
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletTeneligliptin Ditosylate Dihydrate›18.92mg / 1 tablet
Manufacturer / importer
대웅바이오(주)
Appearance
Orange oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202202724 · Approved 2022.07.01 · Insurance code 694003800

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who takes it
Adults
Adult dose
This drug is generally administered once a day with the evening meal. The 20/1000mg extended-release tablet is taken once a day, one tablet per dose. The 10/750mg or 10/500mg extended-release tablet is taken once a day, two tablets at once per dose. The initial dose should consist of 20mg teneligliptin once daily and the existing dosing of metformin. The maximum recommended dose is 20mg teneligliptin and extended-release metformin.

Ingredients

Manufacturer
대웅바이오(주)

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

View approved original text

This drug is used to assist patients with type 2 diabetes who are taking teneligliptin and metformin together in controlling their blood sugar levels. It helps them manage blood sugar effectively alongside dietary adjustments and exercise treatment. This contributes to maintaining stable blood sugar levels, thereby enabling a healthy lifestyle. Therefore, this medicine is used to improve blood sugar control in diabetes patients.

How to take

Adult dose

This drug is generally administered once a day with the evening meal. The 20/1000mg extended-release tablet is taken once a day, one tablet per dose. The 10/750mg or 10/500mg extended-release tablet is taken once a day, two tablets at once per dose. The initial dose should consist of 20mg teneligliptin once daily and the existing dosing of metformin. The maximum recommended dose is 20mg teneligliptin and extended-release metformin.

Precautions

This drug is used for controlling blood sugar levels. However, it should not be administered to patients with severely impaired kidney function, heart failure, or acute kidney dysfunction. Furthermore, patients undergoing surgery, those with severe infections, or those with severe trauma should temporarily discontinue the medication and restart it once they have recovered. Women who are pregnant or may become pregnant should avoid taking this medication. This drug can rarely cause a severe side effect called lactic acidosis, which can be life-threatening; therefore, if symptoms such as difficulty breathing, weakness, or abdominal pain occur, immediate consultation with a doctor is necessary. Additionally, there is a risk of hypoglycemia, so blood sugar changes should be closely monitored when used with insulin or sulfonylurea medications. Patients with severely impaired liver function or those who consume excessive alcohol should also avoid taking this medication. Regular monitoring of kidney function and blood tests during treatment is important. This drug is not recommended for nursing women, and safety in children has not been established. Elderly patients may have a risk of declining kidney function, necessitating dosage adjustments and regular testing. In case of overdose, appropriate treatment should be sought immediately, and blood dialysis may be helpful. This medication should be kept out of the reach of children and should not be transferred to other containers. During treatment, if there are sudden severe abdominal pains, difficulty breathing, rashes, or blisters, the doctor should be notified immediately.

Side effects and when to seek care immediately

Serious side effects

Lactic acidosis, severe hypoglycemia, bowel obstruction, liver dysfunction, interstitial pneumonia, similar dermatitis, acute pancreatitis, severe allergic reactions (urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor), respiratory problems (cough, difficulty breathing), liver abnormalities (jaundice, yellowing of skin or eyes, generalized malaise), severe neurological symptoms (sudden and severe headache, confusion, seizures, paralysis, vision field changes)

Mild side effects

  • Hypoglycemia
  • constipation
  • dizziness
  • headache
  • stomatitis
  • abdominal bloating
  • cold sweat
  • rash
  • itching
  • allergic dermatitis
Show 25 more
  • joint pain
  • fatigue
  • increased serum potassium levels
  • dyspepsia
  • diarrhea
  • nausea
  • fatigue
  • upper respiratory infection
  • rhinitis
  • increased blood sugar
  • hyperglycemia
  • hypercholesterolemia
  • hyperlipidemia
  • urticaria
  • cataract
  • glaucoma
  • blurred vision
  • dizziness
  • anemia
  • depression
  • insomnia
  • increased blood pressure
  • abnormal blood sugar
  • increased blood sugar
  • polyuria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C room temperature. Proper storage will help maintain the drug’s efficacy and safety.

Appearance and packaging

Appearance

Orange oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.